Case Report: Evolution of intratumoral spatial heterogeneity assessed by [68Ga]Ga-DOTA-NOC PET/CT during dinutuximab beta therapy in pediatric high-risk neuroblastoma - Poll - MDSpire

Case Study: Changes in Intratumoral Spatial Heterogeneity Monitored by [68Ga]Ga-DOTA-NOC PET/CT During Dinutuximab Beta Treatment in Pediatric Patients with High-Risk Neuroblastoma

  • By

  • Yueran Chen

  • Qinfeng Xu

  • Haoyan Zhang

  • Yongjun Fang

  • Guoqiang Shao

  • July 21, 2026

Share

Original Source(s)

Case Report: Evolution of intratumoral spatial heterogeneity assessed by [68Ga]Ga-DOTA-NOC PET/CT during dinutuximab beta therapy in pediatric high-risk neuroblastoma

  • by Yueran Chen, Qinfeng Xu, Haoyan Zhang, Yongjun Fang, Guoqiang Shao

  • July 21, 2026

Related Content

Troponin Screening and Major Cardiovascular Adverse Events During Immune Checkpoint Inhibitor Therapy

Targeting the AHR–IDO1–kynurenine pathway in TREM2+ macrophages restores antitumor immunity in thyroid cancer

Association between preoperative neutrophil percentage-to-albumin ratio and survival outcomes in patients with colorectal cancer undergoing radical surgery: a retrospective study with external validation